- Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
-
Rhee CK, Ha JH, Yoon JH, Cho BS, Min WS, Yoon HK, Lee JW
- KMID: 2374041
- Yonsei Med J.
- 2016 Mar;57(2):365-372.
- doi: 10.3349/ymj.2016.57.2.365
PURPOSE: The development of bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic stem cell transplantation (HSCT) deteriorates patients' quality of life. This study aimed to analyze the prevalence, clinical features, risk... -
- CITED
-
- Close
- SHARE
-
- Close
